Corrigendum to "Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)": [ESMO Open 7 (2024) 100552]

I Hartlapp ¹, D Valta-Seufzer ¹, J T Siveke ²

¹Department of Internal Medicine II, Medical Oncology and Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg.
²Department of Medical Oncology, Bridge Institute of Experimental Tumor Therapy, University Medicine Essen, Essen; Division of Solid Tumor Translational Oncology (DKTK Partner Site Essen, DKFZ Heidelberg), West German Cancer Center, University Medicine Essen, Essen.
³Comprehensive Cancer Center München, Klinikum rechts der Isar, Technical University of Munich, School of Medicine and Health, Munich, Bavaria, Germany.
⁴Hämatologisch-Onkologische Praxis Eppendorf (HOPE), Hamburg and University Cancer Center Hamburg (UCCH), Hamburg, Germany.
⁵Department of Internal Medicine 5, Hematology and Medical Oncology, Paracelsus Medical University, Nürnberg.
⁶Department of Internal Medicine III, SLK-Clinics Heilbronn GmbH, Heilbronn.
⁷Department of Gastroenterology and Hepatology, University Hospital Cologne, Cologne.
⁸Division of Oncology and Hematology, Charité Campus Mitte, Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin.
⁹Clinic for Gastroenterology, Hepatology and GI-Oncology, München Klinik Bogenhausen, Munich.
¹⁰Department of Internal Medicine I, Kliniken Nordoberpfalz AG, Klinikum Weiden, Weiden.
¹¹Department of Medical Oncology and Comprehensive Cancer Center, Ludwig Maximilians University-Grosshadern, Munich.
¹²Department of Internal Medicine I, Ulm University Hospital, Ulm.
¹³Department of Biometrics, ClinAssess GmbH, Leverkusen.
¹⁴Clinical Research, AIO Studien gGmbH, Berlin.
¹⁵Department of General, Visceral, Transplantation, Vascular and Pediatric Surgery and Comprehensive Cancer Center Mainfranken Würzburg, University Hospital Würzburg, Würzburg.
¹⁶Department of Haematology, Oncology and Palliative Care Medicine, Asklepios Hospital Barmbek, Hamburg, Germany.

⁰Department of Internal Medicine II, Medical Oncology and Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg.

ESMO Open +

|

May 4, 2024

Summary

No abstract available on PubMed